GUGGENHEIM CAPITAL LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 74 filers reported holding FATE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$45,733
-83.1%
21,572
-62.1%
0.00%
-100.0%
Q2 2023$270,648
-17.6%
56,859
-1.3%
0.00%
-33.3%
Q1 2023$328,304
-73.1%
57,597
-52.4%
0.00%
-72.7%
Q4 2022$1,220,053
-57.2%
120,917
-5.0%
0.01%
-57.7%
Q3 2022$2,851,000
-17.8%
127,218
-9.1%
0.03%
-3.7%
Q2 2022$3,468,000
-32.4%
139,974
+5.7%
0.03%
-12.9%
Q1 2022$5,132,000
-44.1%
132,375
-15.6%
0.03%
-35.4%
Q4 2021$9,179,000
+10.9%
156,888
+12.3%
0.05%
-4.0%
Q3 2021$8,278,000
-8.4%
139,663
+34.1%
0.05%
-5.7%
Q2 2021$9,041,000
+3.5%
104,174
-1.7%
0.05%
-7.0%
Q1 2021$8,734,000
+3.9%
105,930
+14.6%
0.06%
+7.5%
Q4 2020$8,403,000
+260.5%
92,408
+58.5%
0.05%
+211.8%
Q3 2020$2,331,000
+16.0%
58,308
-0.4%
0.02%
+6.2%
Q2 2020$2,009,000
+167.2%
58,558
+72.9%
0.02%
+100.0%
Q1 2020$752,000
+92.3%
33,868
+69.6%
0.01%
+166.7%
Q4 2019$391,000
+98.5%
19,965
+57.8%
0.00%
+50.0%
Q3 2019$197,000
+358.1%
12,653
+19.0%
0.00%
Q3 2017$43,000
+30.3%
10,636
+3.3%
0.00%
Q2 2017$33,00010,3000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$11,083,3302.77%
Redmile Group, LLC 13,169,057$43,194,5072.61%
SUPERSTRING CAPITAL MANAGEMENT LP 497,360$1,631,3412.06%
Boxer Capital, LLC 8,215,910$26,948,1851.42%
Deep Track Capital, LP 5,572,607$18,278,1510.55%
Vestal Point Capital, LP 2,000,000$6,560,0000.49%
Bruce & Co., Inc. 300,000$984,0000.32%
Octagon Capital Advisors LP 520,800$1,708,2240.27%
Integral Health Asset Management, LLC 850,000$2,788,0000.26%
Bellevue Group AG 4,839,779$15,874,4750.26%
View complete list of FATE THERAPEUTICS INC shareholders